Alfa Transformers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:09 am

Competitors of Alfa Transformers Ltd

All Competitor Stocks of Alfa Transformers Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:05 am

Below is a detailed analysis of the quarterly data for Alfa Transformers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 4.87 Cr.. The value appears to be declining and may need further review. It has decreased from 12.49 Cr. (Mar 2025) to 4.87 Cr., marking a decrease of 7.62 Cr..
• For Expenses, as of Jun 2025, the value is 4.86 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.85 Cr. (Mar 2025) to 4.86 Cr., marking a decrease of 6.99 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.64 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.63 Cr..
• For OPM %, as of Jun 2025, the value is 0.21%. The value appears to be declining and may need further review. It has decreased from 5.12% (Mar 2025) to 0.21%, marking a decrease of 4.91%.
• For Other Income, as of Jun 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.33 Cr. (Mar 2025) to 0.11 Cr., marking a decrease of 0.22 Cr..
• For Interest, as of Jun 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.42 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 0.27 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.27 Cr..
• For Profit before tax, as of Jun 2025, the value is -0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.28 Cr. (Mar 2025) to -0.53 Cr., marking a decrease of 0.81 Cr..
• For Tax %, as of Jun 2025, the value is -24.53%. The value appears to be improving (decreasing) as expected. It has decreased from 139.29% (Mar 2025) to -24.53%, marking a decrease of 163.82%.
• For Net Profit, as of Jun 2025, the value is -0.40 Cr.. The value appears to be declining and may need further review. It has decreased from -0.12 Cr. (Mar 2025) to -0.40 Cr., marking a decrease of 0.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.44. The value appears to be declining and may need further review. It has decreased from -0.13 (Mar 2025) to -0.44, marking a decrease of 0.31.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:00 am

Growth

Last Updated: September 5, 2025, 2:11 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Alfa Transformers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 19, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 19, the value is -1.54. This value is below the healthy minimum of 5. It has increased from -3.77 (Mar 18) to -1.54, marking an increase of 2.23.
• For Diluted EPS (Rs.), as of Mar 19, the value is -1.54. This value is below the healthy minimum of 5. It has increased from -3.77 (Mar 18) to -1.54, marking an increase of 2.23.
• For Cash EPS (Rs.), as of Mar 19, the value is -0.20. This value is below the healthy minimum of 3. It has increased from -2.19 (Mar 18) to -0.20, marking an increase of 1.99.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 23.37. It has increased from 21.48 (Mar 18) to 23.37, marking an increase of 1.89.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 43.05. It has decreased from 46.84 (Mar 18) to 43.05, marking a decrease of 3.79.
• For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 70.73. It has increased from 62.39 (Mar 18) to 70.73, marking an increase of 8.34.
• For PBDIT / Share (Rs.), as of Mar 19, the value is 1.75. This value is below the healthy minimum of 2. It has increased from 0.47 (Mar 18) to 1.75, marking an increase of 1.28.
• For PBIT / Share (Rs.), as of Mar 19, the value is 0.41. This value is within the healthy range. It has increased from -1.09 (Mar 18) to 0.41, marking an increase of 1.50.
• For PBT / Share (Rs.), as of Mar 19, the value is -1.57. This value is below the healthy minimum of 0. It has increased from -3.75 (Mar 18) to -1.57, marking an increase of 2.18.
• For Net Profit / Share (Rs.), as of Mar 19, the value is -1.54. This value is below the healthy minimum of 2. It has increased from -3.75 (Mar 18) to -1.54, marking an increase of 2.21.
• For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is -1.54. This value is below the healthy minimum of 2. It has increased from -3.75 (Mar 18) to -1.54, marking an increase of 2.21.
• For PBDIT Margin (%), as of Mar 19, the value is 2.47. This value is below the healthy minimum of 10. It has increased from 0.75 (Mar 18) to 2.47, marking an increase of 1.72.
• For PBIT Margin (%), as of Mar 19, the value is 0.58. This value is below the healthy minimum of 10. It has increased from -1.74 (Mar 18) to 0.58, marking an increase of 2.32.
• For PBT Margin (%), as of Mar 19, the value is -2.22. This value is below the healthy minimum of 10. It has increased from -6.00 (Mar 18) to -2.22, marking an increase of 3.78.
• For Net Profit Margin (%), as of Mar 19, the value is -2.18. This value is below the healthy minimum of 5. It has increased from -6.01 (Mar 18) to -2.18, marking an increase of 3.83.
• For NP After MI And SOA Margin (%), as of Mar 19, the value is -2.18. This value is below the healthy minimum of 8. It has increased from -6.01 (Mar 18) to -2.18, marking an increase of 3.83.
• For Return on Networth / Equity (%), as of Mar 19, the value is -6.60. This value is below the healthy minimum of 15. It has increased from -17.47 (Mar 18) to -6.60, marking an increase of 10.87.
• For Return on Capital Employeed (%), as of Mar 19, the value is 0.91. This value is below the healthy minimum of 10. It has increased from -2.19 (Mar 18) to 0.91, marking an increase of 3.10.
• For Return On Assets (%), as of Mar 19, the value is -2.28. This value is below the healthy minimum of 5. It has increased from -4.21 (Mar 18) to -2.28, marking an increase of 1.93.
• For Long Term Debt / Equity (X), as of Mar 19, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 18) to 0.01, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 19, the value is 0.33. This value is within the healthy range. It has decreased from 0.48 (Mar 18) to 0.33, marking a decrease of 0.15.
• For Asset Turnover Ratio (%), as of Mar 19, the value is 1.01. It has increased from 0.78 (Mar 18) to 1.01, marking an increase of 0.23.
• For Current Ratio (X), as of Mar 19, the value is 1.50. This value is within the healthy range. It has increased from 1.17 (Mar 18) to 1.50, marking an increase of 0.33.
• For Quick Ratio (X), as of Mar 19, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 18) to 0.97, marking an increase of 0.23.
• For Inventory Turnover Ratio (X), as of Mar 19, the value is 4.36. This value is within the healthy range. It has increased from 3.37 (Mar 18) to 4.36, marking an increase of 0.99.
• For Interest Coverage Ratio (X), as of Mar 19, the value is 0.88. This value is below the healthy minimum of 3. It has increased from 0.17 (Mar 18) to 0.88, marking an increase of 0.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 0.22. This value is below the healthy minimum of 3. It has increased from -0.41 (Mar 18) to 0.22, marking an increase of 0.63.
• For Enterprise Value (Cr.), as of Mar 19, the value is 24.11. It has decreased from 32.12 (Mar 18) to 24.11, marking a decrease of 8.01.
• For EV / Net Operating Revenue (X), as of Mar 19, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.69 (Mar 18) to 0.37, marking a decrease of 0.32.
• For EV / EBITDA (X), as of Mar 19, the value is 15.07. This value exceeds the healthy maximum of 15. It has decreased from 92.08 (Mar 18) to 15.07, marking a decrease of 77.01.
• For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 18) to 0.35, marking a decrease of 0.23.
• For Price / BV (X), as of Mar 19, the value is 1.08. This value is within the healthy range. It has decreased from 1.70 (Mar 18) to 1.08, marking a decrease of 0.62.
• For Price / Net Operating Revenue (X), as of Mar 19, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 18) to 0.35, marking a decrease of 0.23.
• For EarningsYield, as of Mar 19, the value is -0.06. This value is below the healthy minimum of 5. It has increased from -0.10 (Mar 18) to -0.06, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness